$41.28
-0.72[-1.71%]
At close: May 17
$41.28
0[0.00%]
After Hours: 6:55PM EDT
Apellis Pharmaceuticals
(NASDAQ:APLS)Apellis Pharmaceuticals Stock (NASDAQ:APLS), Earnings Estimates, EPS, and Revenue
Apellis Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jul 29
EPS Estimate
$-0.310
Quarterly Revenue Estimate
$193.6M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$524.1M
Analyze the earnings history of Apellis Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals | -$1.02 | -$0.31 | — | — | $94.97M | $193.61M | — | — | 07/29/2024 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.56 | -$0.52 | -$0.54 | -3.85% | $44.85M | $163.35M | $172.32M | 5.49% | 05/07/2024 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.50 | -$0.69 | -$0.73 | -5.80% | $22.66M | $143.59M | $146.38M | 1.94% | 02/27/2024 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.75 | -$0.85 | -$1.17 | -37.65% | $22.06M | $99.74M | $110.40M | 10.69% | 11/01/2023 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.46 | -$1.32 | -$1.02 | 22.73% | $16.32M | $70.25M | $94.97M | 35.19% | 07/31/2023 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.42 | -$1.46 | -$1.56 | -6.85% | $14.38M | $26.10M | $44.85M | 71.82% | 05/04/2023 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.61 | -$1.57 | -$1.50 | 4.46% | $60.29M | $24.19M | $22.66M | -6.31% | 02/21/2023 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.57 | -$1.45 | -$1.75 | -20.69% | $5.65M | $21.59M | $22.06M | 2.16% | 11/07/2022 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$2.72 | -$1.36 | -$1.46 | -7.35% | $623.00K | $16.94M | $16.32M | -3.65% | 08/08/2022 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$2.32 | -$1.32 | -$1.42 | -7.58% | $0.00 | $12.57M | $14.38M | 14.41% | 05/04/2022 | Get Alert |
| APLS | Apellis Pharmaceuticals | $0.93 | -$1.54 | -$1.61 | -4.55% | $250.00M | $8.78M | $60.29M | 586.67% | 02/28/2022 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.79 | -$1.75 | -$1.57 | 10.29% | $646.00K | $7.22M | $5.65M | -21.75% | 11/08/2021 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.57 | -$1.70 | -$2.72 | -60.00% | $0.00 | $810.00K | $623.00K | -23.09% | 08/09/2021 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$2.29 | -$1.62 | -$2.32 | -43.21% | $0.00 | $2.27M | $0.00 | -100.00% | 04/28/2021 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.77 | — | $0.93 | — | $0.00 | $96.09M | $250.00M | 160.17% | 02/25/2021 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.09 | — | -$1.79 | — | $0.00 | — | $646.00K | — | 11/02/2020 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.12 | — | -$1.57 | — | $0.00 | — | $0.00 | — | 07/31/2020 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$0.87 | — | -$2.29 | — | $0.00 | — | $0.00 | — | 04/29/2020 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$0.65 | — | -$1.77 | — | $0.00 | — | $0.00 | — | 02/27/2020 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$0.64 | — | -$1.09 | — | $0.00 | — | $0.00 | — | 11/05/2019 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$0.61 | -$0.77 | -$1.12 | -45.45% | $0.00 | — | $0.00 | — | 07/31/2019 | Get Alert |
FAQ
When is Apellis Pharmaceuticals (NASDAQ:APLS) reporting earnings?
Apellis Pharmaceuticals (APLS) is scheduled to report earnings on July 29, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
What were the latest earnings per share (EPS) for Apellis Pharmaceuticals (NASDAQ:APLS)?
The Actual EPS was $-0.54, which missed the estimate of $-0.52.
What were Apellis Pharmaceuticals’s (NASDAQ:APLS) revenues?
The Actual Revenue was $172.3M, which beat the estimate of $163.3M.
Browse earnings estimates, EPS, and revenue on all stocks.